Difficulty: Medium
Average Score: 66%
Testbank
The nurse is caring for a client experiencing metastatic cancer-related pain. Which drug of choice does the nurse anticipate being ordered?
Correct answer
C
Rationale
Morphine (MS Contin) is the drug of choice for managing metastatic cancer-related pain due to its potent analgesic properties and ability to provide effective relief from severe pain associated with cancer progression.
Morphine is an opioid analgesic that is specifically indicated for moderate to severe pain, making it suitable for clients with metastatic cancer who often experience significant pain levels. It works by binding to opioid receptors in the brain, altering the perception of pain and providing relief.
A: Ibuprofen (Motrin) is a nonsteroidal anti-inflammatory drug (NSAID) that may be effective for mild to moderate pain but is generally insufficient for the severe pain associated with metastatic cancer.
B: Alprazolam (Xanax) is an anti-anxiety medication that does not address pain management and is not indicated for the treatment of cancer-related pain, making it inappropriate for this client's needs.
D: Propofol (Diprivan) is an anesthetic agent primarily used for sedation and does not have analgesic properties to manage pain, thus it is not suitable for treating metastatic cancer-related pain.
Morphine is an opioid analgesic that is specifically indicated for moderate to severe pain, making it suitable for clients with metastatic cancer who often experience significant pain levels. It works by binding to opioid receptors in the brain, altering the perception of pain and providing relief.
A: Ibuprofen (Motrin) is a nonsteroidal anti-inflammatory drug (NSAID) that may be effective for mild to moderate pain but is generally insufficient for the severe pain associated with metastatic cancer.
B: Alprazolam (Xanax) is an anti-anxiety medication that does not address pain management and is not indicated for the treatment of cancer-related pain, making it inappropriate for this client's needs.
D: Propofol (Diprivan) is an anesthetic agent primarily used for sedation and does not have analgesic properties to manage pain, thus it is not suitable for treating metastatic cancer-related pain.